The Cuban pharmaceutical is administered by injections that step up the healing of deep ulcers caused by diabetes, a major cause of lower limb amputations in Mexico.
The medication, which was developed by the Havana-based Genetic Engineering and Biotechnology Center, reduces the risk of complications such as gangrene or infections.
The registration of the pharmaceutical was announced in Havana by the first meeting of the Mexico-Cuba Health Cooperation Group with the presence of Mexican Health minister Jose Narros.
During the meeting the two sides agreed to look at new lines of research on diseases with strong impact on the people, such as cancer, hypertension, mental and genetic disorders.
- Countries: Cuba
- Jamaica-Cuba Friendship Association Pays Tribute to Amb. Elinor Felix
- CARICOM reaffirms great value of relations with Cuba
- CARICOM | Cuba reinforces its ties with the Caribbean
- CUBA says it's not intimidated by US measures to reinforce the blockade
- CUBA Will Stand With Venezuela Despite US Restrictions
Latest from Calvin G. Brown
- BARBADOS | The time to invest in BPO in the Caribbean is now!
- CARICOM vital to regional development: Grenada’s new envoy
- Russia Calls US Intervention in Venezuela 'Unacceptable'
- JAMAICA | Earnings of US$3.6 Billion Expected from Tourism
- CARICOM again calls for non-intervention and dialogue in Venezuela